Company Quick10K Filing
Ozop Surgical
10-Q 2020-03-31 Filed 2020-07-02
10-K 2019-12-31 Filed 2020-05-14
10-Q 2019-09-30 Filed 2019-11-14
S-1 2019-09-13 Public Filing
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-01-31 Filed 2018-03-06
10-Q 2017-10-31 Filed 2017-12-07
10-Q 2017-07-31 Filed 2017-08-31
10-K 2017-04-30 Filed 2017-07-27
10-Q 2017-02-22 Filed 2017-02-22
10-Q 2016-11-16 Filed 2016-11-16
8-K 2020-07-07 Shareholder Rights, Amend Bylaw, Regulation FD, Exhibits
8-K 2020-06-26 Enter Agreement, Regulation FD, Exhibits
8-K 2020-05-15
8-K 2020-05-13
8-K 2020-04-28
8-K 2020-04-14
8-K 2020-03-27
8-K 2020-02-28
8-K 2020-02-04
8-K 2020-01-21
8-K 2020-01-13
8-K 2020-01-08
8-K 2020-01-02
8-K 2019-12-11
8-K 2019-11-06
8-K 2019-10-18
8-K 2019-10-08
8-K 2019-09-20
8-K 2019-09-18
8-K 2019-08-29
8-K 2019-08-23
8-K 2019-08-19
8-K 2019-07-25
8-K 2019-07-05
8-K 2019-06-05
8-K 2019-05-29
8-K 2019-05-22
8-K 2019-05-03
8-K 2019-04-26
8-K 2019-04-01
8-K 2019-03-27
8-K 2019-03-24
8-K 2019-03-18
8-K 2019-03-07
8-K 2019-02-21
8-K 2019-02-14
8-K 2019-02-13
8-K 2019-02-05
8-K 2019-01-07
8-K 2018-11-15
8-K 2018-11-06
8-K 2018-10-19
8-K 2018-10-01
8-K 2018-08-29
8-K 2018-07-23
8-K 2018-06-28
8-K 2018-05-21
8-K 2018-05-08
8-K 2018-04-13

Ozop Surgical Financials

OZSC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Kibush Capital (DLCR) 0 33% -0.2 -213% 178 3,452 140 46 -380 -374 88
Alkame Holdings (ALKM) 0 11% -0.0 -2,776% 97 4,532 124 13 -2,695 -2,645 0
Vilacto Bio (VIBI) 0 17% -0.0 -3,636% 538 3,960 5 1 -19,550 -19,519 17
Daniels Corporate Advisory (DCAC) 0 22% -0.4 50% 547 2,757 2,368 525 271 343 -129
Ironclad Encryption (IRNC) 0 0.0 -1,440% 585 5,116 0 0 -8,421 -7,101 -150
Mercantil Bank Holding (MBHC) 0 -1.3 0% 8,435,802 7,708,127 0 0 21,974 81,045 -103,579
Jiayin Group (JFIN)
Cerebain Biotech (CBBT) 0 -2.4 -7,969% 22 6,686 0 0 -1,718 -1,399 3,294
HyperSolar (HYSR) 0 1.4 131% 174 6,528 0 0 228 1,247 1,711
Rennova Health (RNVA) 0 8% -1.3 -236% 16,574 76,464 13,138 1,065 -39,132 -22,172 28,583
Yinghong Guangda Technology (UBLI) 0 24% 0.0 0 21 1,377 326 -1,329 -1,280 -0
ProGreen (PGUS) 0 0% -0.1 -176% 1,863 6,266 61 0 -3,277 -210 17
PropTech Acquisition Corp (PTACU)
9F (JFU)
Data Call Technologies (DCLT) 0 70% 0.7 -21% 101 73 463 323 -21 -19 -13
Ozop Surgical (OZSC) 0 90% -0.7 -71% 6,256 10,414 85 76 -4,437 -2,958 1,985
Intercloud Systems (ICLD) 0 21% -1.3 -92% 9,928 40,762 10,074 2,119 -9,147 -8,136 10,297
PetLife Pharmaceuticals (PTLF) 0 -0.1 -47,202% 8 1,981 0 0 -3,708 -3,708 205
Futu (FHL)
OriginClear (OCLN) 0 11% -0.4 -648% 1,287 20,610 2,696 290 -8,338 -7,771 3,125

Balance Sheet ($'000)2016-11-162017-02-222017-04-302017-07-312017-10-312018-01-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash15115027579515651
Accounts Receivable29258852434662337
Inventory246242388
PP&E161877101010378
Assets59685843381,2601,0336596594106,256
Accounts Payable
Long-Term Debt6159351,2551,4621,7141,986
Liabilities5968565843382,6422,9733,0083,3653,68310,414
Stockholders' Equity5-15-13-49-1,381-1,940-2,348-2,706-3,273-4,158
Income Statement ($'000)2016-11-162017-02-222017-04-302017-07-312017-10-312018-01-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue5552101065748236
Cost of Revenue06425009
Gross Profit0423248227
R&D04853103
SG&A-8-22-23-19-9-28517825120163120
Tax0000000000
Net Income0-18-202-80-607-596-904-1,917-1,616
Cash Flow ($'000)2016-11-162017-02-222017-04-302017-07-312017-10-312018-01-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-2004-30-311-478-287-251-210
Cash Investing-1300-200
Cash Financing-2-15292200406